China NMPA Product Recall - Hemodynamic and Electrophysiological Recording System

Siemens Healthcare GmbH has initiated a voluntary recall of its Hemodynamic and Electrophysiological Recording System, as announced by the National Medical Products Administration (NMPA) of China on November 14, 2022. The recall, identified under NMPA Index No. JGXX-2022-10276, stems from a reported system error affecting specific models and batches of the device. This regulatory action falls under a Class III recall, which typically signifies situations where the use of, or exposure to, a violative product is not likely to cause adverse health consequences. While less severe than Class I or Class II recalls, a Class III recall still necessitates corrective measures to address product deficiencies. The manufacturer, Siemens Healthcare GmbH, is proactively addressing the issue by voluntarily recalling the affected systems. Customers and healthcare providers utilizing the Hemodynamic and Electrophysiological Recording System with Registration Certificate No. 20223070202 are advised to consult the detailed "Medical Device Recall Event Report Form" attachment for comprehensive information regarding the specific models, specifications, and batches involved. This document, hosted by the National Medical Products Administration, underscores the NMPA's role in overseeing medical device safety and ensuring manufacturers address product-related issues to protect public health.